BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35866553)

  • 21. Reference Pricing Changes The 'Choice Architecture' Of Health Care For Consumers.
    Robinson JC; Brown TT; Whaley C
    Health Aff (Millwood); 2017 Mar; 36(3):524-530. PubMed ID: 28264955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in estimated Medicare prescription drug plan costs and affordability for beneficiaries living in different states.
    Davis MM; Patel MS; Halasyamani LK
    J Gen Intern Med; 2007 Feb; 22(2):257-63. PubMed ID: 17356996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of preventable acute care spending to total spending for high-cost Medicare patients.
    Joynt KE; Gawande AA; Orav EJ; Jha AK
    JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.
    Narang AK; Nicholas LH
    JAMA Oncol; 2017 Jun; 3(6):757-765. PubMed ID: 27893028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prices And Cost Sharing For Psychotherapy In Network Versus Out Of Network In The United States.
    Benson NM; Song Z
    Health Aff (Millwood); 2020 Jul; 39(7):1210-1218. PubMed ID: 32634359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020.
    Chua KP; Conti RM; Becker NV
    JAMA Netw Open; 2021 Oct; 4(10):e2129894. PubMed ID: 34661662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemwide provider performance in a Medicaid program. Profiling the care of patients with chronic illnesses.
    Powe NR; Weiner JP; Starfield B; Stuart M; Baker A; Steinwachs DM
    Med Care; 1996 Aug; 34(8):798-810. PubMed ID: 8709661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health care for children and youth in the United States: 2001 annual report on access, utilization, quality, and expenditures.
    Elixhauser A; Machlin SR; Zodet MW; Chevarley FM; Patel N; McCormick MC; Simpson L
    Ambul Pediatr; 2002; 2(6):419-37. PubMed ID: 12437388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of "Defensive Medicine" on the Costs of Diabetes and Associated Conditions.
    Pierce AT; Sheaffer WW; Lu PG; Davila VJ; Soh IY; Meltzer EC; Aiello F; Tarsa SJ; Stone WM; Meltzer AJ
    Ann Vasc Surg; 2022 Nov; 87():231-236. PubMed ID: 35595208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geographic Variation in Medicare Fee-for-Service Health Care Expenditures Before and After the Passage of the Affordable Care Act.
    Sood N; Yang Z; Huckfeldt P; Escarce J; Popescu I; Nuckols T
    JAMA Health Forum; 2021 Dec; 2(12):e214122. PubMed ID: 35977300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of expanded mental health benefits on treatment costs.
    Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
    J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State-Level Variation In Low-Value Care For Commercially Insured And Medicare Advantage Populations.
    Do LA; Koethe BC; Daly AT; Chambers JD; Ollendorf DA; Wong JB; Fendrick AM; Neumann PJ; Kim DD
    Health Aff (Millwood); 2022 Sep; 41(9):1281-1290. PubMed ID: 36067429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Will choice-based reform work for Medicare? Evidence from the Federal Employees Health Benefits Program.
    Florence CS; Atherly A; Thorpe KE
    Health Serv Res; 2006 Oct; 41(5):1741-61. PubMed ID: 16987300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
    Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract.
    McWilliams JM; Landon BE; Chernew ME
    JAMA; 2013 Aug; 310(8):829-36. PubMed ID: 23982369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members.
    Johnson RE; Goodman MJ; Hornbrook MC; Eldredge MB
    Med Care; 1997 Nov; 35(11):1119-31. PubMed ID: 9366891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tiered cost sharing and health care demand.
    Ackley CA
    J Health Econ; 2022 Sep; 85():102663. PubMed ID: 35944308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.